Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
基本信息
- 批准号:10632345
- 负责人:
- 金额:$ 7.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
The successful sequencing of the human genome and the evolution of human health services research in the
post-genomic era have offered unprecedented opportunities to transform patient care in digestive diseases.
Over the past decade, Weill Cornell Medicine (WCM) has made major investments in biomedical research, as
well as research training and infrastructure. This application from WCM requests support for the research
training of 4 clinical and non-clinical postdoctoral fellows in a new multidisciplinary research training program
(MRTP) in Gastroenterology and Hepatology, with WCM providing funding for an additional training slot. The
objective is to recruit outstanding candidates with solid foundations in basic science and train them to apply
their knowledge and skills towards addressing important clinically unmet needs in the prevention, diagnosis,
and treatment of patients with digestive diseases. MRTP trainees will receive program support for 2 years
during which they will follow a structured and rigorous postdoctoral training program. The MRTP will be a joint
effort of 28 eminent preceptors from WCM, Memorial Sloan Kettering Cancer Center (MSKCC) and the
Rockefeller University (RU), which constitute a dense network of collaborative researchers, who are
international leaders in fields directly relevant to gastroenterology and hepatology. These preceptors have
been organized into 3 themed, but interconnected units of research training: gastrointestinal malignancies, liver
diseases and regeneration, and mucosal immunology and inflammation. These training units will enable the
development of content-specific educational programming, as well as increase the efficiency administration
within the training program. Oversight will be provided by a Research Training Executive Committee consisting
of the Program Director and 2 Associate Program Directors, who will also serve as leaders of the training units,
as well as 3 additional members who will provide specific guidance on clinical/epidemiologic research, on
achieving and maintaining diversity within the training program, and on mentoring. We have also assembled an
outstanding roster of internal and external advisory board members with a mandate to evaluate the program
and provide specific recommendations to improve both its quality and efficiency. The MRTP's highly
personalized training program will include 1) individual development plans; 2) rigorous research training; 3)
hands-on experience in cutting-edge methodologies; and 4) an integrated curriculum. Trainees will further
benefit from the extensive institutional resources of WCM, MSKCC and RU. Based upon the levels of interest
in our fellowship programs, we anticipate a substantial pool of highly qualified clinical and non-clinical
candidates for the proposed MRTP, which will maintain a strong diversity focus. Through its rigorous,
structured and highly personalized curriculum, this new training program seeks to train future leaders in
digestive disease research who are prepared to translate their findings towards improving patient care.
项目摘要
人类基因组测序的成功和人类健康服务研究的发展
后基因组时代为改变消化系统疾病的患者护理提供了前所未有的机会。
在过去的十年中,威尔康奈尔医学(WCM)在生物医学研究方面进行了重大投资,
以及研究培训和基础设施。WCM的这份申请要求支持这项研究
在一个新的多学科研究培训方案中培训4名临床和非临床博士后研究员
在胃肠病学和肝病学方面,WCM为额外的培训名额提供资金。的
目标是招募在基础科学方面有坚实基础的优秀候选人,并培养他们应用
他们的知识和技能,以解决重要的临床未满足的需要,在预防,诊断,
以及消化系统疾病患者的治疗。MRTP学员将获得为期2年的计划支持
在此期间,他们将遵循一个结构化和严格的博士后培训计划。MRTP将是一个联合
来自WCM,纪念斯隆凯特琳癌症中心(MSKCC)和
洛克菲勒大学(RU),构成了一个密集的合作研究人员网络,他们是
胃肠病学和肝病学领域的国际领导者。这些导师有
被组织成3个主题,但相互关联的研究培训单位:胃肠道恶性肿瘤,肝脏
疾病和再生,以及粘膜免疫学和炎症。这些培训单位将使
制定具体内容的教育方案,以及提高行政效率
在训练计划中。将由一个研究培训执行委员会进行监督,
项目主任和2名副项目主任,他们也将担任培训单位的领导,
以及另外3名将提供临床/流行病学研究具体指导的成员,
在培训计划中实现和保持多样性,以及指导。我们还组织了一个
内部和外部咨询委员会成员的杰出名册,其任务是评估该计划
并提出具体建议,以提高其质量和效率。MRTP的高度
个性化的培训计划将包括1)个人发展计划; 2)严格的研究培训; 3)
尖端方法的实践经验;和4)综合课程。学员将进一步
受益于WCM、MSKCC和RU的广泛机构资源。根据兴趣的程度
在我们的奖学金计划中,我们预计将有大量高素质的临床和非临床
建议的MRTP的候选人,这将保持一个强大的多样性重点。通过其严格的,
这个新的培训计划结构化且高度个性化,旨在培养未来的领导者,
消化系统疾病的研究谁准备转化为改善病人护理他们的发现。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
randy s longman其他文献
randy s longman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('randy s longman', 18)}}的其他基金
A randomized, placebo-controlled clinical trial examining the efficacy of Fecal Microbiota Transplantation (FMT) and subsequent dietary fiber in patients with moderate ulcerative colitis (MINDFUL)
一项随机、安慰剂对照临床试验,检验粪便微生物群移植 (FMT) 和随后的膳食纤维对中度溃疡性结肠炎 (MINDFUL) 患者的疗效
- 批准号:
10631895 - 财政年份:2021
- 资助金额:
$ 7.66万 - 项目类别:
A randomized, placebo-controlled clinical trial examining the efficacy of Fecal Microbiota Transplantation (FMT) and subsequent dietary fiber in patients with moderate ulcerative colitis (MINDFUL)
一项随机、安慰剂对照临床试验,检验粪便微生物群移植 (FMT) 和随后的膳食纤维对中度溃疡性结肠炎 (MINDFUL) 患者的疗效
- 批准号:
10183772 - 财政年份:2021
- 资助金额:
$ 7.66万 - 项目类别:
A randomized, placebo-controlled clinical trial examining the efficacy of Fecal Microbiota Transplantation (FMT) and subsequent dietary fiber in patients with moderate ulcerative colitis (MINDFUL)
一项随机、安慰剂对照临床试验,检验粪便微生物群移植 (FMT) 和随后的膳食纤维对中度溃疡性结肠炎 (MINDFUL) 患者的疗效
- 批准号:
10385825 - 财政年份:2021
- 资助金额:
$ 7.66万 - 项目类别:
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
TL1A 对结肠炎中第 3 组先天淋巴细胞的调节
- 批准号:
10357907 - 财政年份:2020
- 资助金额:
$ 7.66万 - 项目类别:
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
TL1A 对结肠炎中第 3 组先天淋巴细胞的调节
- 批准号:
9886697 - 财政年份:2020
- 资助金额:
$ 7.66万 - 项目类别:
TL1A Regulation of Group 3 Innate Lymphoid Cells in Colitis
TL1A 对结肠炎中第 3 组先天淋巴细胞的调节
- 批准号:
10589869 - 财政年份:2020
- 资助金额:
$ 7.66万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10400886 - 财政年份:2019
- 资助金额:
$ 7.66万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10612780 - 财政年份:2019
- 资助金额:
$ 7.66万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10133062 - 财政年份:2019
- 资助金额:
$ 7.66万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10621459 - 财政年份:2019
- 资助金额:
$ 7.66万 - 项目类别:
相似海外基金
Integrating Treatments for Alcohol Use Disorder into Hepatology Clinics
将酒精使用障碍的治疗纳入肝病诊所
- 批准号:
10785211 - 财政年份:2023
- 资助金额:
$ 7.66万 - 项目类别:
Training Program in Investigative Gastroenterology and Hepatology
胃肠病学和肝病学研究培训计划
- 批准号:
10628499 - 财政年份:2023
- 资助金额:
$ 7.66万 - 项目类别:
Testing an mHealth System for Integrating Alcohol Use Treatment with Hepatology Care for Patients with Alcohol-associated Liver Disease
测试将酒精使用治疗与肝病护理相结合的移动医疗系统,以治疗酒精相关性肝病患者
- 批准号:
10818885 - 财政年份:2023
- 资助金额:
$ 7.66万 - 项目类别:
HEP DART 2021: FRONTIERS IN DRUG DEVELOPMENT FOR HEPATOLOGY
HEP DART 2021:肝病药物开发前沿
- 批准号:
10391910 - 财政年份:2021
- 资助金额:
$ 7.66万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
9922266 - 财政年份:2019
- 资助金额:
$ 7.66万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10400886 - 财政年份:2019
- 资助金额:
$ 7.66万 - 项目类别:
Multidisciplinary Research Training in Gastroenterology and Hepatology
胃肠病学和肝病学多学科研究培训
- 批准号:
10612780 - 财政年份:2019
- 资助金额:
$ 7.66万 - 项目类别:
HEP DART 2019: Frontiers in Drug Development for Hepatology
HEP DART 2019:肝病药物开发前沿
- 批准号:
9914390 - 财政年份:2019
- 资助金额:
$ 7.66万 - 项目类别: